Lymphoma, FollicularLymphoma, Large B-Cell, DiffuseCyclophosphamideDenintuzumab mafodotinDoxorubicin
Dr. Keith A. Lerro, MD
NPI1730161092PAC ID1557416401
- Medicare services, 2024
- 58,424
- Medicare patients, 2024
- 803
- Part D claims, 2024
- 2,954
- Publications
- 1
- Clinical trials
- 3
- Practice address
- 2624 Ortho Dr, Wilson, NC 27893
- Practice phone
- Call (252) 991-5261
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Regional Medical Oncology Center PA
Wilson, North Carolina
Find Dr. Lerro's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Keith A. Lerro is a hematologist and oncologist in Wilson, North Carolina
Dr. Lerro practices at Regional Medical Oncology Center PA in Wilson, North Carolina.
Dr. Lerro's NPI, 1730161092, was assigned on November 14, 2005. Dr. Lerro graduated from Albert Einstein College of Medicine of Yeshiva University in 1997. Dr. Lerro holds North Carolina license 200300489.
NPI and contact details
- NPI
- 1730161092NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1557416401
- NPI enumeration date
- November 14, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (252) 991-5261
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 55
- Medical school graduation
- 1997
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Keith A. Lerro practices at Regional Medical Oncology Center PA in Wilson, North Carolina
Dr. Lerro's primary practice is Regional Medical Oncology Center PA, at 2624 Ortho Dr, Wilson, NC 27893 in Wilson County. The practice phone is (252) 991-5261.
- Regional Medical Oncology Center PA2624 Ortho Dr, Wilson, NC 27893 · Wilson CountyPhone(252) 991-5261
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Keith A. Lerro is affiliated with 6 sites of care and 2 medical groups
Dr. Lerro's primary practice is Regional Medical Oncology Center PA in Wilson, North Carolina. Dr. Lerro is also affiliated with Wilson Medical Center. The medical group on file is Regional Medical Oncology Center. Dmand AI also links Dr. Lerro to 2 more hospitals, 1 group practice or clinic, 1 hospice and 1 medical group, each named with a free account.
Regional Medical Oncology Center PAPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Keith A. Lerro's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lerro practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Regional Medical Oncology Center PA | Available with a free account |
| +5 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Lerro practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Keith A. Lerro is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Dr. Lerro's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lerro is licensed in North Carolina.
Specialties and state licenses
- Hematology and oncology, North CarolinaPrimary
Hematologists and oncologists near Dr. Lerro
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
420hematologists and oncologists in North Carolina
2hematologists and oncologists in Wilson
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Keith A. Lerro billed Medicare for 58,424 services in 2024
CMS data shows 58,424 Medicare services from Dr. Lerro across 40 procedure codes in 2024, for 803 Medicare patients. Medicare paid $1,006,070 for them.
Medicare services, 202458,424
Medicare patients803
Paid by Medicare$1M
Procedure codes40
Dr. Lerro's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 53,1042024: 49,8126%
- Lab and pathology
- 2023: 2,5562024: 2,83811%
- Tests and treatments
- 2023: 2,6032024: 2,596No change
- Office and hospital visits
- 2023: 1,8292024: 1,9688%
- Surgery
- 2023: 1,0632024: 1,18111%
- Other services
- 2023: 2,0342024: 2999%
Where Dr. Lerro's Medicare services took place, 2024
- In an office57,88199%
- In a facility5431%
Dr. Lerro compared with the North Carolina median for hematologists and oncologists, 2024
- Dr. Lerro
- North Carolina median
- Medicare services
- 58,424vs 450129.8 times
- Medicare patients
- 803vs 1804.5 times
- Part D claims
- 2,518vs 3247.8 times
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Lerro's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lerro?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lerro and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Keith A. Lerro treated 803 Medicare patients in 2024, average age 76
CMS counts 803 Medicare patients who saw Dr. Lerro in 2024. The largest group is 75 to 84, with 360 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lerro's median patient age at 71, with 68% women.
Medicare patients, 2024803
Average age76
Average risk score1.77
Also on Medicaid11%
Dr. Lerro's Medicare patients by age, 2024
Dr. Lerro's Medicare patients by sex, 2024
- Women51064%
- Men29336%
Chronic conditions among Dr. Lerro's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis50%
- Diabetes39%
- Cancer36%
- Chronic kidney disease35%
- Osteoporosis35%
- Ischemic heart disease27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lerro's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women68%
- Men31%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Keith A. Lerro wrote 2,954 Medicare Part D claims in 2024
In 2024, Dr. Lerro wrote 2,954 Medicare Part D claims for 472 patients. 52% of them were for generic drugs. CMS names the drug for 2,518 of them, across 63 drugs with 11 or more claims each, at $8,629,072 in total drug cost. In 2023, CMS named 1,985 claims across 52 drugs.
Part D claims, 20242,954
Drugs named by CMS63
Total drug cost$8.6M
Part D patients472
Dr. Lerro's Part D claims by kind of drug, 2024
- Generic1,544 claims52%
- Brand-name1,410 claims48%
Dr. Lerro's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Lerro's Part D claims, 2024
- Opioids7%220 of 2,954 claims
- Antibiotics1%39 of 2,954 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,9852024: 2,51827%
Drugs named by CMS: 63 in 2024, 52 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Keith A. Lerro scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Lerro for performance year 2024, reported as part of a group. Dr. Lerro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Lerro's MIPS scores, performance year 2024
- 88of 100Final score
- 79.2of 100Quality
- 99of 100Promoting Interoperability
- 40of 100Improvement Activities
- 77of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Lerro by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Keith A. Lerro has 1 publication on record
Dmand AI links 1 paper to Dr. Lerro in 2021. Dr. Lerro's most frequent co-authors are J Thaddeus Beck, FACP, MD, Todd Adam Gersten, MD and Maen A. Hussein, MD.
Papers1
Dr. Lerro's most frequent co-authors
- J Thaddeus Beck, FACP, MD1 shared paper
- Todd Adam Gersten, MD1 shared paper
- Maen A. Hussein, MD1 shared paper
Recent publications by Dr. Lerro
See who Dr. Lerro researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lerro works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Keith A. Lerro has worked on 3 clinical trials
Dmand AI links Dr. Lerro to 3 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Small Cell Lung Carcinoma, Carcinoma, Bronchogenic and Lymphoma, Follicular. G1 Therapeutics, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Lerro that name 1 trial.
Clinical trials with Dr. Lerro by phase
- NonePhase 1: no trials
- 2Phase 1/2: 2 trials
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Lerro's trials
- Small Cell Lung Carcinoma
- Carcinoma, Bronchogenic
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
Investigators on the most trials with Dr. Lerro
- Todd Adam Gersten, MD2 shared trials
- Maen A. Hussein, MD2 shared trials
- David Allen Smith, MD2 shared trials
Recent clinical trials with Dr. Lerro
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy (opens in a new tab)
TerminatedPhase 1/2
Small Cell Lung CarcinomaCarcinoma, BronchogenicTopotecanTrilaciclib
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) (opens in a new tab)
CompletedPhase 1/2
Small Cell Lung CarcinomaCarcinoma, BronchogenicCarboplatinEtoposideTrilaciclib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Keith A. Lerro received $134,055 in industry payments from 2016 to 2025
CMS Open Payments shows 2,117 general payments to Dr. Lerro from 123 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 40% of the total. Novartis Pharmaceuticals Corporation paid the most, $51,999. It also lists 1 research payment totaling $1,386 in 2024, naming 1 clinical trial.
General payments to Dr. Lerro by program year, 2016 to 2025
General payments to Dr. Lerro by kind, 2016 to 2025
$134.1Kin total
- Speaker and faculty fees$53,67040%
- Food and beverage$38,50629%
- Consulting fees$23,53018%
- Travel and lodging$8,9957%
- Other$9,3547%
Companies that paid Dr. Lerro the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Keith A. Lerro graduated from Albert Einstein College of Medicine of Yeshiva University
Dr. Lerro graduated from Albert Einstein College of Medicine of Yeshiva University in 1997.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Keith A. Lerro's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Keith A. Lerro
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Keith A. Lerro's NPI number?
Dr. Keith A. Lerro's NPI number is 1730161092. It was assigned on November 14, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Keith A. Lerro?
Dr. Keith A. Lerro is a hematologist and oncologist in Wilson, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Keith A. Lerro practice?
Dr. Lerro practices at 2624 Ortho Dr, Wilson, NC 27893. Dr. Lerro's primary practice is Regional Medical Oncology Center PA in Wilson, North Carolina. Dmand AI also links Dr. Lerro to 2 hospitals, 1 group practice or clinic, 1 hospice and 1 medical group.
What is Dr. Keith A. Lerro's office phone number?
The practice phone on file for Dr. Lerro is (252) 991-5261.
What is Dr. Keith A. Lerro's medical license number?
Dr. Lerro holds North Carolina license 200300489.
Which hospitals is Dr. Keith A. Lerro affiliated with?
Dr. Lerro is affiliated with Wilson Medical Center. Dmand AI links Dr. Lerro to 2 more hospitals.
What medical group is Dr. Keith A. Lerro part of?
Dr. Lerro is linked to Regional Medical Oncology Center. Dmand AI links Dr. Lerro to 1 more medical group.
Does Dr. Keith A. Lerro accept Medicare?
Yes. CMS data shows Dr. Lerro billed Medicare for 58,424 services in 2024, and Dr. Lerro accepts Medicare assignment.
What is Dr. Keith A. Lerro's MIPS score?
Dr. Lerro's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. Keith A. Lerro see?
CMS counts 803 Medicare patients who saw Dr. Lerro in 2024, with an average age of 76.
Show 7 more questionsShow fewer questions
What services does Dr. Keith A. Lerro bill to Medicare?
In 2024, Dr. Lerro's most billed Medicare services were injected or infused drug (J0897), injected or infused drug (J3111) and injected or infused drug (J1437).
Where did Dr. Keith A. Lerro go to medical school?
Dr. Lerro graduated from Albert Einstein College of Medicine of Yeshiva University in 1997.
What drugs does Dr. Keith A. Lerro prescribe most?
In 2024 Medicare Part D data, Dr. Lerro's most prescribed drugs by claims were Anastrozole, Procrit and Eliquis.
Has Dr. Keith A. Lerro received payments from drug or device companies?
CMS Open Payments shows $134,055 in general payments to Dr. Lerro from 123 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Keith A. Lerro been practicing?
Dr. Lerro graduated from medical school in 1997, 29 years ago.
Does Dr. Keith A. Lerro do research?
Dmand AI links 1 publication to Dr. Lerro. Dr. Lerro has worked on 3 clinical trials.
Who does Dr. Keith A. Lerro publish with?
Dr. Lerro's most frequent co-authors are J Thaddeus Beck, FACP, MD (1 shared paper), Todd Adam Gersten, MD (1 shared paper) and Maen A. Hussein, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card